Abstracts Archive - Page 2088 of 2425 - ACR Meeting Abstracts

Abstract Number: 2465 • 2013 ACR/ARHP Annual Meeting
Prevelance Of Inflammatory Back Pain and Axial Spondyloarthritis Among University Employees In Izmir, Turkey
Fatos Onen¹, Dilek Solmaz¹, Pinar Cetin¹, Ali Balci², Servet Akar¹ and Nurullah Akkoc¹, ¹Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, ²Radiology, Dokuz Eylul University School of Medicine, izmir, Turkey
Background/Purpose: The prevalence of axial spondyloarthritis (SpA) has not yet been investigated in a population based survey by using new ASAS classification criteria. The aim…
Abstract Number: 2466 • 2013 ACR/ARHP Annual Meeting
Long Term Efficacy Over Five Years Of Adalimumab In Patients With Active Non – Radiographic Axial Spondyloarthritis
Hildrun Haibel¹, Xenofon Baraliakos², Joachim Listing³, Juergen Braun⁴ and Joachim Sieper¹, ¹Charité Universitätsmedizin Berlin, Berlin, Germany, ²Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, ³German Rheumatism Research Center, Berlin, Germany, ⁴Rheumazentrum Ruhrgebiet, Herne, Germany
Background/Purpose: Adalimumab had demonstrated good efficacy in 46 patients with active non-radiographic axial SpA in a 12-weeks, placebo-controlled trial with a 40-weeks, open-label extension.1,2In 19…
Abstract Number: 2467 • 2013 ACR/ARHP Annual Meeting
Response to Tumor Necrosis Factor inhibitors In Axial Spondyloarthritis: Does Sacroiliitis Make Any Difference?
Julien Girodon¹, Vianney Jouhet² and Elisabeth Solau-Gervais¹, ¹Rheumatology, University Hospital of Poitiers, Poitiers, France, ²Informatic, University hospital Bordeaux, Bordeaux, France
Background/Purpose: Axial spondyloarthritis (SpA) are characterized by sacroiliitis. The TNF inhibitors (TNFi) have been proven to be highly effective in ankylosing spondylitis. Recently, adalimumab demonstrate…
Abstract Number: 2468 • 2013 ACR/ARHP Annual Meeting
The Prevalence Of Sjogren’s Syndrome In Patients With Ankylosing Spondylitis
Ayse Balkarli¹, Adem Kucuk², Sahin Temel³, Tayfun Gungor⁴, Ramazan Ucar⁵ and Veli Cobankara⁶, ¹Department of Rheumatology, Pamukkale University School of Medicine, Denizli, Turkey, ²Necmettin Erbakan University, Meram Medical Faculty,Division of Rheumatology, Konya, Turkey, ³Department of Internal Medicine, Pamukkale University, Denizli, Turkey, ⁴Department of Physical medicine and Rehabilitation, Necmettin Erbakan University, Konya, Turkey, ⁵Konya Education and Research Hospital, Department ofInternal Medicine, Konya, Turkey, ⁶Division of Rheumatology, Pamukkale University, Denizli, Turkey
Background/Purpose : Sjögren's syndrome (SS) is a chronic autoimmune inflammatory disease that primarily affects exocrine glands with a prevalence of 1% to 4.8. SS mainly…
Abstract Number: 2469 • 2013 ACR/ARHP Annual Meeting
Radiographic Sacroiliitis Progression In An Early Spondyloarthritis Cohort
Concepcion Castillo-Gallego¹, Eugenio de Miguel², Carmen Martin-Hervas³, Diana Peiteado¹, Leticia Lojo⁴ and Emilio Martin-Mola⁵, ¹Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, ²Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, ³Radiology, Hospital Universitario La Paz, Madrid, Spain, ⁴Rheumatology, Hospital Universitario La Paz, Spain, Spain, ⁵Rheumatology, Hospital Universitario La Paz, Madrid, Spain
Background/Purpose: The improvement of treatment in axial Spondyloarthritis (axSpA) and the development of the ASAS classification criteria have facilitated the early diagnosis and management of…
Abstract Number: 2470 • 2013 ACR/ARHP Annual Meeting
Combined Axial and Peripheral Involvement Is Associated With Miscegenation In A Large and Heterogeneous Brazilian Cohort Of 1505 Patients With Spondyloarthritis
Percival D Sampaio-Barros¹, Mittermayer Santiago², Adriana B. Bortoluzzo², Antonio Carlos Ximenes², José Antonio Braga da Silva², Manoel B Bértolo², Sandra Lúcia Ribeiro², Mauro Keisermann², Rita Menin², Thelma L. Skare², Sueli Carneiro², Valderilio F. Azevedo², Walber P. Vieira², Elisa Albuquerque², Washington A. Bianchi², Rubens Bonfiglioli², Cristiano Campanholo², Hellen M Carvalho², Izaias P. Costa², Angela Luzia B. P. Duarte², Charles Kohem², Nocy Leite², Sonia Lima², Eduardo S. Meirelles², Ivânio A. Pereira², Marcelo M. Pinheiro², Elizandra Polito², Gustavo G. Resende², Francisco AC Rocha³, Maria de Fátima L. C. Sauma², Valéria Valim² and Celio R. Gonçalves², ¹Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²Brazilian Registry of Spondyloarthritis, São Paulo, Brazil, ³Rheumatology, Brazilian Registry of Spondyloarthritis, São Paulo, Brazil
Background/Purpose: Spondyloarthritides (SpA) constitute a group of diseases that can present different patterns according to the genetic background. Brazilis a large country with a heterogeneous…
Abstract Number: 2443 • 2013 ACR/ARHP Annual Meeting
Prevalence Of Coronary Heart Disease In Spondyloarthopathies may Be Increased Due To Higher Prevalence Of Risk Factors As Well As The Disease Itself- A Retrospective Analysis At Single VA Medical Center
Trayton Mains¹ and Vikas Majithia², ¹University of Mississippi Medical Center, Jackson, MS, ²G.V. "Sonny" Montogomery VA Medical Center, Jackson, MS
Background/Purpose: An increased prevalence of cardiovascular disease (CVD) and coronary heart disease (CHD) has been reported in patients with spondyloarthritides (SpA). This study investigated the…
Abstract Number: 2431 • 2013 ACR/ARHP Annual Meeting
Association Of T Follicular Helper / Th17 T Cell and Memory B Cell Populations In Rheumatoid Arthritis With Disease Activity and Therapy With TNF Antagonists
Marc C. Levesque¹, Camilla Macedo², Lisa Boyette², Kevin Hadi³, Erich R Wilkerson⁴, Diana Metes², Larry W. Moreland⁵ and Mandy J. McGeachy⁶, ¹Division of Rheumatology and Clinical Immunology, University of Pittsburgh Department of Medicine, Pittsburgh, PA, ²University of Pittsburgh, Pittsburgh, PA, ³Univeristy of Pittsburgh, Pittsburgh, PA, ⁴Medicine, University of Pittsburgh, Pittsburgh, PA, ⁵Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁶Medicine, Division of Rheumatology and Clinical Immunology, Univeristy of Pittsburgh, Pittsburgh, PA
Background/Purpose: Autoreactive memory B cells and T cells contribute to the pathogenesis of rheumatoid arthritis (RA) through production of antibodies and cytokines that activate monocytes…
Abstract Number: 2432 • 2013 ACR/ARHP Annual Meeting
Characterization Of Lung Inflammation and Identification Of Shared Citrullinated Targets In The Lungs and Joints Of Early RA
Vijay Joshua¹, Gudrun Reynisdottir², Jimmy Ytterberg¹, Marianne Engström², Anders Eklund³, Magnus Skold³, Per-Johan Jakobsson⁴, Johan Rönnelid⁵, Vivianne Malmström⁶, Lars Klareskog⁴, Johan Grunewald³ and Anca I Catrina⁴, ¹Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, ²Department of Medicine, Rheumatology unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, ³Department of Medicine, Division of Respiratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, ⁴Medicine, Rheumatology unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, ⁵Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, ⁶Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: To investigate if lung changes are present in rheumatoid arthritis (RA) patients early in the disease process and to address the contribution of these…
Abstract Number: 2433 • 2013 ACR/ARHP Annual Meeting
Evaluation Of The Two-Step Referral Strategy For Axial Spondyloarthritis In The Spondyloarthritis Caught Early Cohort
Ozair Abawi¹, Rosaline van den Berg¹, Désirée van der Heijde², Manouk de Hooge¹, Pauline Bakker¹, Monique Reijnierse³, Tom Huizinga¹, Jürgen Braun⁴ and Floris van Gaalen¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Radiology, Leiden University Medical Center, Leiden, Netherlands, ⁴Rheumazentrum Ruhrgebiet, Herne, Germany
Background/Purpose: Currently, in primary care no satisfactory referral model exists for referral to the rheumatologist of patients with chronic back pain (CBP) with possible axial…
Abstract Number: 2434 • 2013 ACR/ARHP Annual Meeting
Syndesmophyte Distribution Along The Vertebral Rim In Ankylosing Spondylitis Is Non-Random
Sovira Tan¹, Abhijit Dasgupta¹, Jianhua Yao², John A. Flynn³, Lawrence Yao² and Michael M. Ward⁴, ¹NIAMS/NIH, Bethesda, MD, ²Diagnostic Radiology, NIH Clinical Center, Bethesda, MD, ³Dept of Medicine, Johns Hopkins University, Baltimore, MD, ⁴Bldg 10 CRC Rm 4-1339, NIAMS/NIH, Bethesda, MD
Background/Purpose: Syndesmophytes, the hallmark of structural damage in ankylosing spondylitis (AS), are typically visualized 2-dimensionally by radiographs. However, these projections only allow a limited view…
Abstract Number: 2435 • 2013 ACR/ARHP Annual Meeting
Prevalence Of Inflammatory Lesions MRI-Spine In Patients With Chronic Back Pain Of ≤2 Years Duration Included In The SPACE-Cohort
Manouk de Hooge¹, Rosaline van den Berg², Monique Reijnierse³, Victoria Navarro-Compán², Floris van Gaalen², Karen Fagerli⁴, Maureen C. Turina⁵, Maikel van Oosterhout⁶, Roberta Ramonda⁷, Tom Huizinga² and Désirée van der Heijde⁸, ¹Leiden University Medical Center, Leiden, Netherlands, ²Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Radiology, Leiden University Medical Center, Leiden, Netherlands, ⁴Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁵Department of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, ⁶Rheumatology, GHZ Hospital, Gouda, Netherlands, ⁷Rheumatology Unit, University of Padova, Padova, Italy, ⁸Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Inflammatory lesions of the spine are not included in the ASAS definition of a positive MRI for fulfilment of the ASAS axial spondyloarthritis (axSpA)…
Abstract Number: 2436 • 2013 ACR/ARHP Annual Meeting
Classification Of Axspa Based On Positive Imaging (Radiographs and/or MRI of the Sacroiliac Joints) By Local Rheumatologists Or Radiologists Versus Central Trained Readers In The DESIR-Cohort
Rosaline van den Berg¹, Grégory Lenczner², Fabrice Thévenin³, Pascal Claudepierre⁴, Antoine Feydy³, Monique Reijnierse⁵, Alain Saraux⁶ and Désirée van der Heijde¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Radiology, Henri Mondor Teaching Hospital, AP-HP, Créteil, France, ³Radiology B, Paris Descartes University, Côchin Hospital, APHP, Paris, France, ⁴Rheumatology, Henri Mondor Teaching Hospital, AP-HP, Créteil, France, ⁵Radiology, Leiden University Medical Center, Leiden, Netherlands, ⁶Department of rheumatology and unit of immunology (EA 2216), Université Brest Occidentale, Brest, France
Background/Purpose: Sacroiliitis on MRI and X-rays play an important role in the ASAS axial spondyloarthritis (axSpA) criteria1. Though, recognition of sacroiliitis on X-rays (X-SI) and…
Abstract Number: 2437 • 2013 ACR/ARHP Annual Meeting
Prevalence Of Axial Spondyloarthritis In The United States Among Patients With Chronic Back Pain and Other Spondyloarthritis-Related Features
Atul A. Deodhar¹, Philip J. Mease², Jeffrey R. Curtis³, Piyalal M. Karunaratne⁴, Kailash Malhotra⁴ and Aileen L. Pangan⁴, ¹Oregon Health & Science University, Portland, OR, ²University of Washington and Swedish Medical Center, Seattle, WA, ³University of Alabama at Birmingham, Birmingham, AL, ⁴AbbVie Inc., North Chicago, IL
Background/Purpose: The age-adjusted prevalence of spondyloarthritis (SpA) has been estimated to be 0.9-1.4% of the US population using the Amor and ESSG criteria. The objective…
Abstract Number: 2438 • 2013 ACR/ARHP Annual Meeting
Effectiveness Of Exercise Program in Ankylosing Spondylitis: Meta-Analysis Of Randomized Controlled Trials
Virginie Pécourneau¹, Arnaud L. Constantin² and Alain G. Cantagrel³, ¹CHU Toulouse, Toulouse, France, ²Rheumatology, Purpan University Hospital, Toulouse Cedex 9, France, ³Dept of Rheumatology, Hopital Purpan, Toulouse CEDEX 9, France
Effectiveness of exercise programs in ankylosing spondylitis: meta-analysis of randomized controlled trialsVirginie PÃ©courneau1, Adeline Ruyssen-Witrand1, Thomas Barnetche2, Alain Cantagrel1, Arnaud Constantin1.1 Centre de Rhumatologie, HÃxpital…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].